These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 17283585

  • 1. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
    Tse KC, Lam MF, Tang SC, Tang CS, Chan TM.
    Lupus; 2007; 16(1):46-51. PubMed ID: 17283585
    [Abstract] [Full Text] [Related]

  • 2. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM.
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [Abstract] [Full Text] [Related]

  • 3. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.
    Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.
    Tse KC, Li FK, Tang S, Tang CS, Lai KN, Chan TM.
    Lupus; 2005 Dec; 14(12):947-52. PubMed ID: 16425574
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB, Won S, Bae SC.
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 9. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L, Y T, X P, L W, H W, Z S, H Z, Z H, MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group.
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
    Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T.
    Clin Exp Rheumatol; 2010 Jul; 28(1):6-12. PubMed ID: 20346231
    [Abstract] [Full Text] [Related]

  • 11. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
    Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F.
    Clin Exp Rheumatol; 2013 Jul; 31(1):62-8. PubMed ID: 22935463
    [Abstract] [Full Text] [Related]

  • 12. Good response of membranous lupus nephritis to tacrolimus.
    Maruyama M, Yamasaki Y, Sada K, Sarai A, Ujike K, Maeshima Y, Nakamura Y, Sugiyama H, Makino H.
    Clin Nephrol; 2006 Apr; 65(4):276-9. PubMed ID: 16629227
    [Abstract] [Full Text] [Related]

  • 13. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D.
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 15. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC, To CH, Yu KL, Ho LY.
    Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
    Cortés-Hernández J, Torres-Salido MT, Medrano AS, Tarrés MV, Ordi-Ros J.
    Nephrol Dial Transplant; 2010 Dec; 25(12):3939-48. PubMed ID: 20538787
    [Abstract] [Full Text] [Related]

  • 17. Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria.
    Gordon S, Denunzio T, Uy A.
    Hawaii J Med Public Health; 2013 Sep; 72(9 Suppl 4):18-23. PubMed ID: 24052913
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K.
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [Abstract] [Full Text] [Related]

  • 20. Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy.
    Kanda H, Kubo K, Tateishi S, Sato K, Yonezumi A, Yamamoto K, Mimura T.
    Lupus; 2005 Jul; 14(4):288-92. PubMed ID: 15864915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.